Continued from page 1

Peanut Corp. of America President Stewart Parnell said the company is working with federal authorities.

NEW YORK

Survey: 3.4 million are victims of stalking

NEW YORK — An estimated 3.4 million Americans identified themselves as victims of stalking during a one-year span, according to federal crime experts who on Tuesday released the largest-ever survey of the aggravating and often terrifying phenomenon.

About half of the victims experienced at least one unwanted contact per week from a stalker, and 11 percent had been stalked for five or more years, according to the report by the Justice Department’s Bureau of Justice Statistics. It covered a 12-month period in 2005-06.

The study was described as a groundbreaking effort to analyze the scope and varying forms of stalking, which had not been featured in previous versions of the National Crime Victimization Survey.

The researchers defined stalking as a course of conduct, directed at a specific person on at least two separate occasions, that would cause a reasonable person to feel fear. The most commonly reported types of stalking were unwanted phone calls (66 percent), unsolicited letters or e-mail (31 percent), or having rumors spread about the victim (36 percent).

More than one-third of the victims reported being followed or spied upon; some said they were tracked by electronic monitoring, listening devices or video cameras.

Nearly 75 percent of victims knew their stalker in some capacity, most commonly a former spouse or ex-boyfriend or girlfriend.

NORTH CAROLINA

Study: VapoRub not for infants

WINSTON-SALEM — A U.S. study suggests the popular cold treatment Vicks VapoRub may create respiratory problems for infants and small children.

The study by Wake Forest University Baptist Medical Center, published in the journal Chest, found the menthol compound may stimulate mucus production and airway inflammation, which can have severe effects on infants or young children because of the small size of their airways.

Current labeling of the Procter & Gamble product indicates that the Vicks product should not be used on children under 2 years of age.

From wire dispatches and staff reports